Degeneration of photoreceptors caused by excessive illumination, inherited mutations, or aging is the principal pathology of blinding diseases. Pharmacological compounds that stabilize the visual receptor rhodopsin and modulate the cellular pathways triggering death of photoreceptors could avert this pathology. Interestingly, flavonoids can modulate the cellular processes, such as oxidative stress, inflammatory responses, and apoptosis, that are activated during retinal degeneration. As we found previously, flavonoids also bind directly to unliganded rod opsin, enhancing its folding, stability, and regeneration. In addition, flavonoids stimulate rhodopsin gene expression. Thus, we evaluated the effect of two main dietary flavonoids, quercetin and myricetin, in ATP-binding cassette subfamily A member 4−/−/retinol dehydrogenase 8−/− and wild-type BALB/c mice susceptible to light-induced photoreceptor degeneration. Using in vivo imaging, such as optical coherence tomography, scanning laser ophthalmoscopy, and histologic assessment of retinal morphology, we found that treatment with these flavonoids prior to light insult remarkably protected retina from deterioration and preserved its function. Using high-performance liquid chromatography–mass spectrometry analysis, we detected these flavonoids in the eye upon their intraperitoneal administration. The molecular events associated with the protective effect of quercetin and myricetin were related to the elevated expression of photoreceptor-specific proteins, rhodopsin and cone opsins, decreased expression of the specific inflammatory markers, and the shift of the equilibrium between cell death regulators BCL2-associated X protein (BAX) and B-cell lymphoma 2 toward an antiapoptotic profile. These results were confirmed in photoreceptor-derived 661W cells treated with either H2O2 or all-trans-retinal stressors implicated in the mechanism of retinal degeneration. Altogether, flavonoids could have significant prophylactic value for retinal degenerative diseases.
展开▼
机译:由过度照明、遗传突变或衰老引起的光感受器退化是致盲性疾病的主要病理。稳定视觉受体视紫红质并调节触发光感受器死亡的细胞途径的药理化合物可以避免这种病理。有趣的是,类黄酮可以调节在视网膜变性过程中激活的细胞过程,例如氧化应激、炎症反应和细胞凋亡。正如我们之前发现的,类黄酮还直接与未配体的杆状视蛋白结合,增强其折叠、稳定性和再生。此外,类黄酮刺激视紫红质基因表达。因此,我们评估了两种主要膳食类黄酮,槲皮素和杨梅素,在 ATP 结合盒亚家族 A 成员 4-/-/-/-和对光诱导的光感受器变性敏感的野生型 BALB/c 小鼠中的影响。使用体内成像,例如光学相干断层扫描、扫描激光检眼镜检查和视网膜形态的组织学评估,我们发现在光损伤前用这些类黄酮治疗显着保护视网膜免于恶化并保持其功能。使用高效液相色谱-质谱分析,我们在腹膜内给药时在眼睛中检测到这些黄酮类化合物。与槲皮素和杨梅素保护作用相关的分子事件与光感受器特异性蛋白、视紫红质和视锥视蛋白的表达升高、特异性炎症标志物表达降低以及细胞死亡调节因子 BCL2 相关 X 蛋白 (BAX) 和 B 细胞淋巴瘤 2 之间的平衡向抗凋亡特征的转变有关。这些结果在用 H2O2 或与视网膜变性机制有关的全反式视网膜压力源处理的光感受器衍生的 661W 细胞中得到证实。总而言之,类黄酮对视网膜退行性疾病具有显着的预防价值。
展开▼